在高流症后,辅助勃起功能的长期预测因素:患者的个人资料比栓塞技术更重要
Ludovico Maria Basadonna1, Federica Passarelli1, Michele Rizzo2
1Department of Urology, IRCCS Fondazione Ca' Granda, Policlinico di Milano, Milan, Italy.
The journal of sexual medicine
|October 26, 2025
概括
超选择性动脉栓塞对于高流动性嗜食症 (HFP) 是有效的,但近一半的患者需要长期的辅助勃起功能 (EF). 基线EF和并发症预测结果,指导个性化患者护理.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 干预性放射学 干预性放射学
- 性医学性医学性医学性医学
背景情况:
- 高流 (HFP) 是一种罕见的疾病,通常是由创伤引起的,导致动脉洞鼻.
- 超选择性动脉栓塞是当保守方法失败时HFP的主要治疗方法.
- 有限的长期数据存在于勃起功能 (EF) 结果后栓塞为HFP.
研究的目的:
- 在通过栓塞治疗HFP的患者中评估长期勃起功能 (EF).
- 为了确定HFP的栓塞后EF受损的预测因素.
主要方法:
- 来自六个中心的41名HFP患者 (2002-2024) 的回顾性分析.
- 通过阴茎多普勒超声波,血液气体分析和选择性尾动脉造影证实了诊断.
- 使用IIEF-5和勃起硬度得分评估前和后栓塞EF;逻辑和线性回归分析预测因素.
主要成果:
- 随访时间中位数为44个月;IIEF-5中位数从25分降至21分.
- 严重的ED发生在2.4%,但46.3%需要辅助EF (药物,设备).
- 较高的基线查尔森并发症指数 (CCI) 和较低的基线IIEF-5预测了更糟糕的EF结果和需要辅助EF的需求.
结论:
- 对HFP的超选择性栓塞证明了长期的疗效,通常保持EF.
- 伴随性疾病和基线EF显著预测了在栓塞后需要辅助勃起功能.
- 个性化患者辅导和长期监测对于管理HFP患者的栓塞后至关重要.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
311
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
311
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
554
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
554
Pulmonary Embolism III: Nursing Management
353
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
353
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457


